ChromaDex rebrands as Niagen Bioscience; Nasdaq ticker becomes NAGE

Niagen Bioscience, Inc.

Name change from ChromaDex Corporation to Niagen Bioscience, Inc. effective March 19, 2025.
Common stock begins trading under new ticker symbol 'NAGE' on Nasdaq; CUSIP unchanged.
Rebranding reflects focus on flagship Niagen ingredient and NAD+ healthy-aging science; no operational changes.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Niagen Bioscience, Inc.: Company amended Certificate of Incorporation to change name to Niagen Bioscience, Inc (effective 2025-03-19).

Change: charter amendment
Effective: 2025-03-19

Exact text from the filing

On March 17, 2025, Niagen Bioscience, Inc. (formerly ChromaDex Corporation) (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to change the Company’s name to “Niagen Bioscience, Inc.,” effective as of 12:01 a.m. Eastern Time on March 19, 2025.

View on SEC.gov

Browse all governance changes →

Niagen Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-013681

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.